Your session is about to expire
← Back to Search
Robotics
Robot-Mediated Therapy for Autism
N/A
Waitlist Available
Led By Rebecca Landa, PhD, CCC-SLP
Research Sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Child participants must be between the ages of 4 years, 0 months and 8 years, 11 months.
Children must meet criteria for ASD or autism on the Autism Diagnostic Observation Schedule (ADOS-2; Lord et al., 2012) plus receive a clinical judgment of pervasive developmental disorder not otherwise specified (PDD-NOS) or autism by the study team.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly throughout intervention schedule (8-14 weeks)
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether an interactive, social robotics program can help children with ASD understand emotions and interact better with others. Families will be assigned at random to either the robot intervention or no intervention, and children will be assessed before and after the 8-14 week trial period.
Who is the study for?
This trial is for children aged 4 to nearly 9 with Autism Spectrum Disorders (ASD) who can speak enough to do a Module 2 ADOS-2 test. They need a clinical ASD or autism diagnosis and their caregivers must commit to the study duration and testing schedule. Families should primarily speak English at home.
What is being tested?
The study tests an interactive robot program designed to help kids with ASD understand and recognize emotions better. It involves random assignment of participants into two groups: one using the robot intervention, and another without any new intervention, over an 8-14 week period.
What are the potential side effects?
Since this is a behavioral intervention involving robots, there are no direct medical side effects like you'd expect from medication. However, it's important to monitor how each child reacts emotionally or behaviorally to the interaction with the robot.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child is between 4 and 8 years old.
Select...
My child has been diagnosed with autism or PDD-NOS by both a test and a doctor.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weekly throughout intervention schedule (8-14 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly throughout intervention schedule (8-14 weeks)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in baseline emotions accurately identified on the Transporters Quiz
Secondary study objectives
Number of prompt-free intervals during the treatment sessions
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Robot-mediated InterventionExperimental Treatment1 Intervention
Families assigned to the robot condition will be asked to complete pre-test assessments and post testing as well as to participate in the robot intervention. The intervention will last for a 8-14 week period in which families will bring their child in 2-3 times a week on average for approximately 30 minutes until 24 treatment sessions have been completed. Children will receive one-on-one intervention with an interventionist facilitating the child's interactions with the robot.
Group II: Treatment as UsualActive Control1 Intervention
Families assigned to the TAU condition will be asked to complete pre-test assessments and approximately 8-14 weeks later return to complete post-test assessments where the social emotions activity will be retested. During the 8-14 weeks between the testing assessments, families in the TAU condition will also receive a weekly email asking about their child's media use.
Find a Location
Who is running the clinical trial?
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Lead Sponsor
89 Previous Clinical Trials
24,823 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
3,492 Patients Enrolled for Autism Spectrum Disorder
Aetna, Inc.Industry Sponsor
14 Previous Clinical Trials
6,330,032 Total Patients Enrolled
Rebecca Landa, PhD, CCC-SLPPrincipal InvestigatorHugo W. Moser Research Institute at Kennedy Krieger, Inc.
7 Previous Clinical Trials
1,163 Total Patients Enrolled
7 Trials studying Autism Spectrum Disorder
1,163 Patients Enrolled for Autism Spectrum Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child is between 4 and 8 years old.My child has been diagnosed with autism or PDD-NOS by both a test and a doctor.My family speaks English at least half the time at home.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment as Usual
- Group 2: Robot-mediated Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.